Role of Routine HIV Testing in Concentrated Epidemics Operations Research for Optimizing the HIV Testing Program in an Urban Canadian Setting K Vasarhelyi,

Slides:



Advertisements
Similar presentations
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Advertisements

Modelling potential impact of expanding access to anti- retroviral therapy on the concentrated HIV epidemic in Viet Nam Masaya Kato, Reuben Granich, Hoang.
National Institute for Public Health and the Environment HIV, HCV, and HBV in injecting drug users in Europe Mirjam Kretzschmar Centre for Infectious Disease.
Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.
Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
AIDS 2014 – Ending the adolescent AIDS epidemic Ungdom og hiv Anne May Andersen, Norad.
Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.
2,100,000 Number of pregnant women with HIV/AIDS 200,000Number of pregnant women receiving PMTCT 630,000Number of MTCT new infections 2,000,000Number of.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.
Background Donor Suitability Consultation was held in Atlanta June 26-27, 2001 To review and consult on the 1994 CDC Guidelines for Preventing Transmission.
STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence.
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
Concepts in Infectious Disease Epidemiology: Models & Prediction David Vlahov, Ph. D.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV resource needs case studies: Belarus and Armenia
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
AIDS IN ASIA – PRIORITIZING AND SUSTAINING THE RESPONSE IN THE ECONOMIC CRISIS Hanoi September 2009 ADB Consultant Ross McLeod.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
To Increase Investment in Syringe Exchange in the U.S. would be Cost-saving. Results from modeling hypothetical syringe coverage levels INTL AIDS CONF.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Slide 1 of 42 IAS–USA AU EDITED FINAL: Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,
British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, FRCPC, FCCP, FRSC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
1 Where have we failed? Findings of the Commission on AIDS in Asia Tim Brown East-West Center Modes of Transmission in the Philippines Stakeholders’ meeting.
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? 1. Julius Center, University.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 1.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
ELIZABETH MZIRAY Health, Nutrition and Population Department World Bank.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
Building Awareness for Action Why MARPs Matter and What Matters for MARPs An Assessment of Policy toward Most-at-Risk Populations (MARPs) for HIV/AIDS.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
#AIDS2016 HOW TO LAUNCH PROGRAMMES FOR PEOPLE WHO USE SUBSTANCES AND ARE AFFECTED BY HIV ACROSS MORE GENERALIZED HIV EPIDEMIC SETTINGS.
Quick Review This presentation is the first in a series of presentations intended to familiarize you with disparities calculation Part I: YOU ARE HERE!
20:20 Vision Making new and old money work better
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
UNITAID PSI HIV SELF-TESTING AFRICA
Strengthening the Focus of Municipal HIV Responses on Key Populations
HIV testing guidance: know, treat, prevent
Needle and syringe exchange and working with injecting drug users
How were funds spent and what did the study recommend?
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Parastu Kasaie Johns Hopkins University
Edward Mbizo Sibanda, (MSc) Right to Care
Ann Robbins HIV/STD Prevention and Care Branch August 6, 2012
The HIV Epidemic among People who Inject Drugs
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV/AIDS Expert Group Activities to implement the strategy
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Role of Routine HIV Testing in Concentrated Epidemics Operations Research for Optimizing the HIV Testing Program in an Urban Canadian Setting K Vasarhelyi, S Kok, JSG Montaner, AR Rutherford, R Barrios, K McPherson, M Thumath, L Tran, A Nathoo, R Gustafson

Collaboration of Academic and Public Health Partners BC Centre for Excellence in HIV/AIDS Vancouver Coastal Health Providence Health Care The IRMACS Centre A poster for the Vancouver Coastal Health / Providence Health Care social marketing campaign promoting routine HIV testing The IRMACS Centre The BC Centre for Excellence in HIV/AIDS & Providence Health Care

BACKGROUND

Stakeholder’s Questions 1.Should we do it? Can routine voluntary HIV testing make a useful contribution to controlling the HIV epidemic in Vancouver? 2.How can we do it? What is the best way to integrate routine voluntary HIV testing into the current testing program?

The HIV Epidemic in Vancouver Concentrated epidemic MSM, IDU, sex workers 1 HIV prevalence ~12 / >200 new diagnoses / year in past 10 years 3 <150 new diagnoses in HIV testing traditionally risk-based No routine testing guidelines in Canada (1)MSM – men who have sex with men; IDU – injection drug user (2)McInnes et al., 2009, Harm Reduction Journal (3)BC Centre for Disease Control (Vancouver’s population 600,000) / Vancouver Coastal Health

Routine Testing Generalized epidemics Lower yield Lower cost/test Risk-based Testing Concentrated epidemics Higher yield Higher cost/test What is the optimal mix of testing methods for Vancouver?

Routine Testing Generalized epidemics Lower yield Lower cost/test Risk-based Testing Concentrated epidemics Higher yield Higher cost/test YIELD COST What is the optimal mix of testing methods for Vancouver?

Objectives Minimize morbidity Minimize mortality Minimize HIV incidence

What is the optimal mix of testing methods for Vancouver? Objective Minimize morbidity Minimize mortality Minimize HIV incidence

Operations Research and Optimization Find best intervention to meet objective Intervention is resource allocation Optimal distribution of new resources Optimal realignment of existing resources

MODEL

Model Development Step 1 Qualitative Model for Cascade of Care Step 1 Qualitative Model for Cascade of Care Step 2 Qualitative Model for HIV Testing Program Step 2 Qualitative Model for HIV Testing Program Step 4 System Dynamics / HIV Transmission Simulation Model of Cascade of Care with Detailed HIV Testing Program Step 4 System Dynamics / HIV Transmission Simulation Model of Cascade of Care with Detailed HIV Testing Program Step 3 Combine

Model Development Step 1 Qualitative Model for Cascade of Care Step 1 Qualitative Model for Cascade of Care Step 2 Qualitative Model for HIV Testing Program Step 2 Qualitative Model for HIV Testing Program Step 4 System Dynamics / HIV Transmission Simulation Model of Cascade of Care with Detailed HIV Testing Program Step 4 System Dynamics / HIV Transmission Simulation Model of Cascade of Care with Detailed HIV Testing Program Step 3 Combine General Population MSM Other Key Populations (IDU, Sex workers)

Qualitative Model of the Cascade of Care Decisions and activities in the HIV care continuum defined through consultations with system experts

Qualitative Model of the Cascade of Care Decisions and activities in the HIV care continuum defined through consultations with system experts DIAGNOSIS LINKAGE TO CARE RETENTION IN CARE

Qualitative Model of the HIV Testing Program Vancouver Coastal Health for STOP HIV/AIDS Project, Vancouver, Canada (2013)

Qualitative Model of the HIV Testing Program Vancouver Coastal Health for STOP HIV/AIDS Project, Vancouver, Canada (2013) Routine Testing in HOSPITALS Routine Testing in HOSPITALS

HIV Testing Resources No $ estimate available Cost of 1 Risk-Based Test > Cost of 1 Routine Test Considered 1:1 to 9:1 cost ratios Number of Tests / Month Total HIV Testing Resources + Cost Ratio

RESULTS

Question 1 Is routine testing effective in reducing HIV incidence in Vancouver? SIMULATON SCENARIO 1.Increase total testing budget by 50%. 2.Invest all new resources in one program: Risk-based testing or Routine testing in high-prevalence settings or Routine testing in hospitals 3.Compare 5-year cumulative incidence.

Relative effectiveness of testing programs in reducing 5-year cumulative HIV incidence Risk-based Testing Up to 83 infections averted in 5 years Routine Testing in Hospitals Up to 104 infections averted in 5 years Routine Testing in High-Prevalence Settings Up to 274 infections averted in 5 years

Question 2 How many infections would be averted by increasing routine testing in hospitals and improving engagement in treatment? SIMULATION SCENARIO 1.Increase total testing budget by 50%. 2.Invest all new resources in routine testing in hospitals. 3.Increase immediate treatment initiation after linkage to care from 38% to 75% and reduce loss to follow- up from 26% to 10%. 4.Compare 5-year cumulative incidence.

Test Cost Ratio Risk-based :Routine Infections Averted Over 5 Years Change in Infections Averted Baseline Engagement Improved Engagement 1: % 5: % 9: % Increasing routine testing in hospitals and improving engagement in treatment

Question 3 How many infections would be averted by realigning existing resources between risk- based and routine testing in hospitals? SIMULATION SCENARIO 1.Keep total testing budget the same. 2.Realign existing resources between risk-based testing and routine testing in hospitals in 5% increments. 3.Compare 5-year cumulative incidence.

Optimal resource allocation to risk-based testing and routine testing in hospitals to minimize HIV incidence Cost Ratio % Resources in Routine Testing in Hospitals Optimal % Hospital Admission s to Test (Current=12%) CurrentOptimal 1:138%0% 3:117%15%10% 5:111%30%32% 7:18%40%59% 9:16%45%83%

Optimal resource allocation to risk-based testing and routine testing in hospitals to minimize HIV incidence Cost Ratio % Resources in Routine Testing in Hospitals Optimal % Hospital Admission s to Test (Current=12%) CurrentOptimal 1:138%0% 3:117%15%10% 5:111%30%32% 7:18%40%59% 9:16%45%83%

CONCLUSIONS

Conclusions Routine HIV testing in Vancouver is likely to be averting infections, especially in high- prevalence settings. In general routine testing may play an important role in controlling concentrated HIV epidemics. Optimizing across the cascade of care could avert additional infections. Realigning existing resources may improve efficiency of the testing program.

Conclusions Next steps include – Morbidity and mortality as optimization objectives – Developing other parts of the model of cascade Operations research and optimization provide powerful methods to inform implementation of WHO guidelines on early treatment initiation.

Collaborators & Sponsors BC Centre for Excellence in HIV/AIDS Silvia Guillemi Guillaume Colley Susan Shurgold Benita Yip Vancouver Coastal Health & Providence Health Care Kendra McPherson Meaghan Thumath Lynn Tran Reka Gustafson Afshan Nathoo Allison Macbeth Chris Buchner Val Munroe Jat Sandhu Ellen Demlow Tim Chu Scott Harrison BC Centre for Disease Control Mark Gilbert Travis Salway Hottes Gina Ogilvie University of Zurich Lukas Ahrenberg IRMACS Pam Borghardt Peter Borwein Brian Corrie Felix Breden Kelly Gardner Alexa van der Waall

Buffer Slide This slide can be lost!